The healthcare sector in the USA is experiencing massive growth, driven by advancements in technology, an aging population, and the demand for innovative solutions.
For investors looking to secure long-term growth, healthcare stocks offer substantial potential.
Below, we dive into the top 10 healthcare stocks in the USA positioned for steady returns over the next decade.
These companies are key players across pharmaceuticals, biotechnology, and medical devices, each with a strong market position and future outlook.
Table of Contents
1. Johnson & Johnson (JNJ)
- Current Price: $162.89
- Market Cap: $428.79 billion
- P/E Ratio: 23.45
- Dividend Yield: 2.80%
- Shareholder Pattern: 70% institutional, 30% retail
- Future Price Prediction (10 Years): $300
Johnson & Johnson is a diversified healthcare giant, leading in pharmaceuticals, medical devices, and consumer health products.
With continuous investment in research and development (R&D) and a strong pipeline of drugs, J&J remains a top pick for healthcare investors.
2. UnitedHealth Group Inc. (UNH)
- Current Price: $520.14
- P/E Ratio: 23.89
- Dividend Yield: 1.39%
- Shareholder Pattern: 75% institutional, 25% retail
- Future Price Prediction (10 Years): $1,100
UnitedHealth Group, a leader in health insurance and data analytics, continues to expand with its Optum division, offering strong revenue growth.
Its business model provides stability and growth, ideal for investors seeking steady returns.
3. Pfizer Inc. (PFE)
- Current Price: $33.56
- Market Cap: $185.02 billion
- P/E Ratio: 9.8
- Dividend Yield: 4.72%
- Shareholder Pattern: 64% institutional, 36% retail
- Future Price Prediction (10 Years): $60
Known for its COVID-19 vaccine success, Pfizer remains focused on innovative therapies and expanding its drug portfolio.
With a high dividend yield and low P/E ratio, Pfizer is attractive for income and growth investors alike.
4. Abbott Laboratories (ABT)
- Current Price: $106.78
- Market Cap: $189.68 billion
- P/E Ratio: 34.32
- Dividend Yield: 1.5%
- Shareholder Pattern: 73% institutional, 27% retail
- Future Price Prediction (10 Years): $220
Abbott Laboratories specializes in medical devices, diagnostics, and nutrition products, showing resilience across various economic conditions.
Its continuous innovation in diagnostics makes it a strong healthcare investment.
5. Merck & Co., Inc. (MRK)
- Current Price: $103.52
- Market Cap: $262.73 billion
- P/E Ratio: 17.95
- Dividend Yield: 2.8%
- Shareholder Pattern: 71% institutional, 29% retail
- Future Price Prediction (10 Years): $200
Merck, a pharmaceutical leader, has a promising portfolio focusing on oncology and immunology.
Known for its strong dividend yield and potential for capital appreciation, Merck is well-positioned for growth.
Also Read :
- Top 10 ESG Stocks for Sustainable Investing in the USA Now
- Top 10 AI Stocks Set to Soar in USA 2024
- What to Expect from the U.S. Stock Market After the 2024 Elections
- Top 10 Penny Stocks to Invest in the US Market for Long-Term Growth
- Top 10 High Dividend Stocks To Invest In The USA Now
- Top 10 High Earning Stocks to Invest in USA 2024
6. Eli Lilly and Company (LLY)
- Current Price: $540.01
- Market Cap: $514.09 billion
- P/E Ratio: 80.12
- Dividend Yield: 0.88%
- Shareholder Pattern: 80% institutional, 20% retail
- Future Price Prediction (10 Years): $1,200
Eli Lilly focuses on innovative treatments in diabetes, oncology, and immunology.
With a robust drug pipeline, it’s considered a high-growth healthcare stock and an excellent long-term investment.
7. Medtronic plc (MDT)
- Current Price: $79.88
- Market Cap: $106.57 billion
- P/E Ratio: 29.88
- Dividend Yield: 3.2%
- Shareholder Pattern: 69% institutional, 31% retail
- Future Price Prediction (10 Years): $160
Medtronic is a leader in medical technology, offering a wide range of healthcare solutions.
Its strong dividend yield and innovative pipeline in cardiac and neurological devices make it a valuable pick for growth and income investors.
8. Amgen Inc. (AMGN)
- Current Price: $262.34
- Market Cap: $140.77 billion
- P/E Ratio: 22.13
- Dividend Yield: 3.22%
- Shareholder Pattern: 78% institutional, 22% retail
- Future Price Prediction (10 Years): $550
Amgen, a biotechnology pioneer, focuses on serious illness treatments with high revenue potential.
Known for its strong financials and dividend, Amgen is appealing for long-term growth.
9. CVS Health Corporation (CVS)
- Current Price: $70.44
- Market Cap: $91.72 billion
- P/E Ratio: 22.91
- Dividend Yield: 2.91%
- Shareholder Pattern: 76% institutional, 24% retail
- Future Price Prediction (10 Years): $150
CVS Health combines pharmacy services with healthcare benefits, providing a unique growth opportunity.
Its commitment to affordable healthcare solutions positions it well for the future.
10. Thermo Fisher Scientific Inc. (TMO)
- Current Price: $485.92
- Market Cap: $194.92 billion
- P/E Ratio: 31.5
- Dividend Yield: 0.22%
- Shareholder Pattern: 82% institutional, 18% retail
- Future Price Prediction (10 Years): $1,000
Thermo Fisher Scientific is a leader in laboratory and medical instruments, playing a key role in the pharmaceutical and biotech industries.
Its innovative products make it a valuable stock for long-term growth.
Top 10 Healthcare Stocks List In USA
| Company Link | Current Market Price | Dividend Yield | Future Price (2034) |
|---|---|---|---|
| Johnson & Johnson | $162.89 | 2.80% | $300 |
| UnitedHealth Group Inc. | $520.14 | 1.39% | $1,100 |
| Pfizer Inc. | $33.56 | 4.72% | $60 |
| Abbott Laboratories | $106.78 | 1.5% | $220 |
| Merck & Co., Inc. | $103.52 | 2.8% | $200 |
| Eli Lilly and Company | $540.01 | 0.88% | $1,200 |
| Medtronic plc | $79.88 | 3.2% | $160 |
| Amgen Inc. | $262.34 | 3.22% | $550 |
| CVS Health Corporation | $70.44 | 2.91% | $150 |
| Thermo Fisher Scientific Inc. | $485.92 | 0.22% | $1,000 |
Conclusion:
The healthcare sector offers vast potential for long-term growth, and these 10 stocks are well-positioned to thrive in the coming decade.
Each of these companies has a unique market presence, strong financials, and a focus on future-ready innovation, making them compelling investments for growth-oriented portfolios.
FAQs on Top 10 Healthcare Stocks for Long-Term Growth in the USA
What are healthcare stocks?
Healthcare stocks represent companies involved in medical services, biotech, pharmaceuticals, and devices.
Why invest in healthcare stocks?
Healthcare is a resilient sector with high demand, offering long-term stability and growth.
Are healthcare stocks safe for long-term investment?
Yes, healthcare stocks often perform well over time, driven by innovation and demand for healthcare services.
What is the best healthcare stock for growth in 2024?
Johnson & Johnson, with its diverse portfolio, is highly recommended for steady growth.
How do I pick the right healthcare stock?
Look for companies with strong financials, innovative products, and positive growth potential.
